The Cannabis ETF (THCX)
ARCA ARCA Primary 
7 Struggling Cannabis Stocks to Sell by 2025
Make no mistake: it's still a time when you should be thinking about which cannabis stocks to sell, not which cannabis stocks to buy. Yes, based on the sheer volume of public comments submitted to the Drug Enforcement Administration ( DEA ) in support of a proposed rescheduling of marijuana, U.S. cannabis legalization progress seemingly keeps moving in the right direction.
Top Cannabis Stocks For Marijuana Investors
The cannabis industry continues to see strong growth. Ever since states began to legalize cannabis the demand for more products has increased. But what are companies doing to meet the needs of consumers? For the last year or so more companies have been working on new projects by entering into strategic partnerships. What a strategic partnership can do is help both parties reach their desired goals they may not have been able to reach alone.
President Biden's Decision Not to Run for a Second Term Could Be a Massive Catalyst for Cannabis Stocks
There hasn't been any significant progress in terms of legalizing marijuana under President Biden. Kamala Harris may be the Democratic nominee, and she's favored marijuana reform in the past.
What Are the Hottest Cannabis Stocks Right Now? 3 Top Picks.
Cannabis stocks have been through an extended period of depression. Overcapacity, regulatory headwinds, competition, and cash burn have contributed to the decline in the cannabis industry.
Cannabis company Tilray made a huge bet on craft beer. It's already paying off.
Almost a year ago to the day, Tilray Brands Inc. made a big bet on craft beer, buying a clutch of brands from Anheuser-Busch, including the popular Shock Top, Montauk Brewery and Redhook Brewery.
High-Potential Canadian Cannabis Stock to Watch in August 2024
The cannabis industry thrives, with Canada at the forefront of this growth. In August, three Canadian cannabis stocks to watch are SNDL Inc. (SNDL), Village Farms International, Inc. (VFF), and Aurora Cannabis Inc. (ACB). These companies have established significant positions in the U.S. market, where the cannabis industry is projected to grow to $41.5 billion by 2025. Recently, discussions around U.S. federal legalization have intensified, with positive headlines suggesting possible legislative changes. This potential shift could further boost these companies' market shares. On the global stage, these companies have expanded their reach, making strategic moves in Europe and Latin America. Investors interested in the cannabis sector should consider technical analysis and proper risk management to navigate this volatile market. Monitoring stock trends and setting stop-loss orders can help mitigate risks.
Top Ancillary Cannabis Stocks to Add to Your Watchlist Before August
The cannabis industry in the United States is experiencing rapid growth. In 2023, the market was valued at $10 billion. Analysts predict it could reach $30 billion by 2025. This surge is fueled by increasing legalization and acceptance. Recently, there have been headlines about potential federal legalization. This would significantly boost the market. Ancillary cannabis stocks, which support the industry without touching the plant, are particularly worth watching. These companies provide essential services and products, ranging from technology to hydroponics. They are crucial for the industry's infrastructure and growth.
KindlyMD(TM) Submits Comment to the Department of Justice Regarding Cannabis Rescheduling
SALT LAKE CITY, UT / ACCESSWIRE / July 25, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, announced today that it has submitted a comment to the U.S. Department of Justice, following its recent proposed rule to reclassify cannabis from Schedule I to Schedule III of the Controlled Substances Act ("CSA"), consistent with the view of the Department of Health and Human Services ("HHS") that cannabis has a currently accepted medical use as well as HHS's views concerning cannabis abuse potential and the level of physical or psychological dependence. For the past 54 years, cannabis has been categorized as a Schedule I controlled substance under the Controlled Substances Act.
3 Cannabis Stocks to Buy on the Dip: July 2024
Why consider a controversial sector such as cannabis stocks? Let's be real – you want to have an opportunity to make serious money.
Top Marijuana Stocks For Investors Who Trade Cannabis Today
The cannabis industry has seen massive growth over the last several years. This success has led to many investing and taking profits. Cannabis once viewed as a taboo substance has turned into one of the biggest consumer products both medically and recreationally. Even with no federal reform and the promise of rescheduling from the DEA operators continue to thrive. Most cannabis businesses have met many obstacles mainly with large state taxes.
Innovative Industrial: Unlocking Value In Cannabis REITs
Innovative Industrial delivered a 69% return over the past year, driven by strategic real estate acquisitions and strong AFFO growth. The global medical cannabis market is projected to grow from $24.87 billion in 2024 to $69.75 billion by 2029, at a CAGR of 22.9%. IIPR maintains a high occupancy rate of 95.2% across 108 properties, with diversified tenant and geographic exposure.
Get Your Money Out of These 3 Cannabis Stocks by 2025
Cannabis stocks have gained in the past couple of months following the federal government's reclassification of the drug. Experts also anticipate that the lobby to lift the ban on the U.S. financial institutions financing cannabis stocks and the reclassification may see the industry market value double to $57 billion by 2028.
